Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022802500> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2022802500 endingPage "166" @default.
- W2022802500 startingPage "166" @default.
- W2022802500 abstract "Mixed dyslipidemia is characterized by increased low-density lipoprotein cholesterol (LDL-C) elevated triglycerides (TGs) and decrease high-density lipoprotein cholesterol (HDL-C). It is more common in diabetes and is associated with an increased risk of coronary artery disease. Monotherapy with statins or fibrates may not effectively control all lipid parameters. The atorvastatin-fenofibrate combination has been shown to have highly beneficial effect on lipid parameters in type 2 diabetes associated with combined hyperlipidemia (CHL). In an open-label study, we evaluated the efficacy of atorvastatin alone and in combination with fenofibrate in 60 types 2 diabetes mellitus patients associated with hyperlipidemia. Patients were randomly assigned to receive atorvastatin 10 mg (Group 1) or combination of atorvastatin 10 mg and fenofibrate 145 mg (Group 2) once daily for 12 weeks. The effect of drugs on lipid profile was evaluated before and after treatment. After 12 weeks, the reduction in total cholesterol (TC), TGs, LDL-C, VLDL-C was 28%, 20%, 37% and 20% in Group 1 (P < 0.001 for all) as compared with 31%, 39%, 33% and 40% in Group 2 (P < 0.001 for all). There was insignificant rise in HDL-C in Group 1 (P = 0.71) and insignificant decrease in HDL-C (P = 0.70) in Group 2. During the combination therapy, the decrease in TC, TGs and VLDL-C was greater than atorvastatin alone. The combination of atorvastatin with fenofibrate in type 2 diabetes patients with CHL may have a favorable effect on some major coronary artery disease risk factors." @default.
- W2022802500 created "2016-06-24" @default.
- W2022802500 creator A5032694935 @default.
- W2022802500 creator A5065553665 @default.
- W2022802500 date "2013-01-01" @default.
- W2022802500 modified "2023-09-26" @default.
- W2022802500 title "A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia" @default.
- W2022802500 cites W2126115073 @default.
- W2022802500 cites W2140937253 @default.
- W2022802500 cites W2400712338 @default.
- W2022802500 doi "https://doi.org/10.4103/2231-4040.116778" @default.
- W2022802500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3777308" @default.
- W2022802500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24083205" @default.
- W2022802500 hasPublicationYear "2013" @default.
- W2022802500 type Work @default.
- W2022802500 sameAs 2022802500 @default.
- W2022802500 citedByCount "11" @default.
- W2022802500 countsByYear W20228025002014 @default.
- W2022802500 countsByYear W20228025002015 @default.
- W2022802500 countsByYear W20228025002016 @default.
- W2022802500 countsByYear W20228025002018 @default.
- W2022802500 countsByYear W20228025002020 @default.
- W2022802500 countsByYear W20228025002021 @default.
- W2022802500 countsByYear W20228025002023 @default.
- W2022802500 crossrefType "journal-article" @default.
- W2022802500 hasAuthorship W2022802500A5032694935 @default.
- W2022802500 hasAuthorship W2022802500A5065553665 @default.
- W2022802500 hasBestOaLocation W20228025001 @default.
- W2022802500 hasConcept C126322002 @default.
- W2022802500 hasConcept C134018914 @default.
- W2022802500 hasConcept C2776999253 @default.
- W2022802500 hasConcept C2777180221 @default.
- W2022802500 hasConcept C2777482532 @default.
- W2022802500 hasConcept C2778096610 @default.
- W2022802500 hasConcept C2778110834 @default.
- W2022802500 hasConcept C2778163477 @default.
- W2022802500 hasConcept C2778213512 @default.
- W2022802500 hasConcept C2778270857 @default.
- W2022802500 hasConcept C2779091943 @default.
- W2022802500 hasConcept C2910068830 @default.
- W2022802500 hasConcept C555293320 @default.
- W2022802500 hasConcept C71924100 @default.
- W2022802500 hasConcept C90924648 @default.
- W2022802500 hasConceptScore W2022802500C126322002 @default.
- W2022802500 hasConceptScore W2022802500C134018914 @default.
- W2022802500 hasConceptScore W2022802500C2776999253 @default.
- W2022802500 hasConceptScore W2022802500C2777180221 @default.
- W2022802500 hasConceptScore W2022802500C2777482532 @default.
- W2022802500 hasConceptScore W2022802500C2778096610 @default.
- W2022802500 hasConceptScore W2022802500C2778110834 @default.
- W2022802500 hasConceptScore W2022802500C2778163477 @default.
- W2022802500 hasConceptScore W2022802500C2778213512 @default.
- W2022802500 hasConceptScore W2022802500C2778270857 @default.
- W2022802500 hasConceptScore W2022802500C2779091943 @default.
- W2022802500 hasConceptScore W2022802500C2910068830 @default.
- W2022802500 hasConceptScore W2022802500C555293320 @default.
- W2022802500 hasConceptScore W2022802500C71924100 @default.
- W2022802500 hasConceptScore W2022802500C90924648 @default.
- W2022802500 hasIssue "3" @default.
- W2022802500 hasLocation W20228025001 @default.
- W2022802500 hasLocation W20228025002 @default.
- W2022802500 hasLocation W20228025003 @default.
- W2022802500 hasLocation W20228025004 @default.
- W2022802500 hasOpenAccess W2022802500 @default.
- W2022802500 hasPrimaryLocation W20228025001 @default.
- W2022802500 hasRelatedWork W1519382273 @default.
- W2022802500 hasRelatedWork W1983615535 @default.
- W2022802500 hasRelatedWork W2019363123 @default.
- W2022802500 hasRelatedWork W2022802500 @default.
- W2022802500 hasRelatedWork W2163292437 @default.
- W2022802500 hasRelatedWork W2378812482 @default.
- W2022802500 hasRelatedWork W2408722788 @default.
- W2022802500 hasRelatedWork W3148001717 @default.
- W2022802500 hasRelatedWork W3173037707 @default.
- W2022802500 hasRelatedWork W4214920461 @default.
- W2022802500 hasVolume "4" @default.
- W2022802500 isParatext "false" @default.
- W2022802500 isRetracted "false" @default.
- W2022802500 magId "2022802500" @default.
- W2022802500 workType "article" @default.